FinTrend
Beacon
日誌
支出
投資
Article
免費工具
ZH
한국어
English
Español
Français
Deutsch
Português
Italiano
繁體中文
登入
Astrazeneca Plc Ordinary Shares(AZN)
Description
一家開發創新藥物與藥品製劑的製藥公司
Key stats
Earnings
2026-05-29
IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
2026-05-27
US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
2026-05-26
DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
2026-05-26
ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS